Skip to content

Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients

Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients With Severe Motor Impairment of the Upper Extremity

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03947645
Enrollment
20
Registered
2019-05-13
Start date
2019-05-02
Completion date
2023-12-31
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke

Brief summary

Chronic stroke patients (\> 6 months) with severe motor impairment of the upper extremity will be enrolled in this single-centre, randomized controlled clinical trial (RCT). All patients will take part in two blocks of high-intense motor training with concurrent neuromuscular stimulation of the paretic upper extremity. In a randomized, cross-over block design, patients will receive transcranial stimulation of either the ipsi- or contralesional hemisphere.

Detailed description

Chronic stroke patients (\> 6 months) with severe motor impairment of the upper extremity and non-proportional recovery will be enrolled in this single-centre, randomized controlled clinical trial (RCT). All patients will take part in two blocks of high-intense motor training with concurrent neuromuscular stimulation of the paretic upper extremity. In a randomized, cross-over block design, patients will receive transcranial stimulation of either the ipsi- or contralesional hemisphere. The primary outcome measure is the Fugl-Meyer Assessment for upper extremity (FM-UE), acquired at baseline, after the intervention period, and at 3 months follow-up. Secondary outcome measures consist of further clinical parameters and biomarkers of corticospinal connectivity.

Interventions

Device: ipsilesional transcranial stimulation, neuromuscular Stimulation over target muscle

Device: contralesional transcranial stimulation, neuromuscular stimulation over target muscle

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Written informed consent * Chronic stage of stroke (\> 6 months) * No active finger extension/hand opening of the paretic side

Exclusion criteria

* Pregnancy * Epilepsy * Metal implants * Pacemaker

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment (Upper Extremity)change from baseline to both directly after intervention and 3 months after

Secondary

MeasureTime frameDescription
Action Research Arm Test (ARAT)change from baseline to both directly after intervention and 3 months afterMotor Impairment of the upper extremity. Several objects in different sizes and weights should be moved by patients.
Arm-Achange from baseline to both directly after intervention and 3 months afterQuestionnaire on capability to care for the paretic arm in different situations of daily living. Scale ranges from 0 (no problems) to 4 (impossible to do).
Modified Ashworth Scale (MAS)change from baseline to both directly after intervention and 3 months afterSpasticity in different body parts. Scale ranges from 0 (no spasticity) to 4 (rigid).
Fugl-Meyer Assessment (Lower Extremity)change from baseline to both directly after intervention and 3 months afterAssessment of motor impairment of the lower extremity.
10m walking testchange from baseline to both directly after intervention and 3 months afterAssessment of motor impairment of the lower extremity.
National Institute of Stroke Scale (NIHSS)baselineAssessment of severity of stroke and neurological deficits. Scale ranges from 0 (normal) to 2, 3 or 4 (depending on the item).
Modified Rankin Scale (mRS)change from baseline to both directly after intervention and 3 months afterDegree of disability after stroke on a scale from 0 (no symptoms) to 6 (dead).
EQ-5Dchange from baseline to both directly after intervention and 3 months afterQuestionnaire on subjective health status. Patients should rate their health status for that day in different tasks of daily living on a scale from no problems, minor problems, moderate problems, big problems to not possible at all.
CAHAI-13change from baseline to both directly after intervention and 3 months afterTest on activities of daily living. Patients should perform several tasks and are scored from 1 (total assist) to 7 (complete independence).
Stroke Impact Scalechange from baseline to both directly after intervention and 3 months afterQuestionnaire on subjective impact of stroke on daily living and health status. Scale ranges from 1 (most negative answer) to 5 (most positive answer).
Barthel Indexchange from baseline to both directly after intervention and 3 months afterQuestionnaire on extent to which patients can perform activities of daily living on their own. Patients can reach 0 (cannot perform any task) to a maximum of 100 points (can do everything on their own).
Hospital Anxiety and Depression Scalechange from baseline to both directly after intervention and 3 months afterQuestionnaire on anxiety and depression. Scale ranges from 0 (most positive answer) to 3 (most negative answer).
Neurological Fatigue Indexchange from baseline to both directly after intervention and 3 months afterQuestionnaire on fatigue in the last two weeks. Scale ranges from no agreement at all, no agreement, agreement to some extent to full agreement.
NEO-Fünf-Faktoren InventarbaselinePersonality questionnaire with 60 statements that patients should rate ranging from strong disagreement, disagreement, neutral, agreement to strong agreement.
Situational Motivation Scalechange from baseline to both directly after intervention and 3 months afterQuestionnaire on motivation to participate in training. Scale ranges from 0 (not correct at all) to 6 (strongly agree).
Berlin Social Support Scalechange from baseline to both directly after intervention and 3 months afterQuestionnaire to evaluate social support. Patients should rate different questions regarding their most important attachment figure ranging from no agreement at all, no agreement, agreement to some extent to full agreement.
Credibility/Expectancy Questionnairechange from baseline to both directly after intervention and 3 months afterQuestionnaire to evaluate expectancies on current program. Scale rangs from 0 (most negative) to 9 (most positive).

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026